Phase II study of Bevacizumab and Erlotinib in previously untreated hepatocellular carcinoma (HCC)
Govindarajan R, Siegel E, Makhoul I, Williamson S. Phase II study of Bevacizumab and Erlotinib in previously untreated hepatocellular carcinoma (HCC). 2010.